natgillin/translations-raw huggingface dataset:
Powder in vial (type I glass), with stopper (chlorobutyl) and aluminium flip-off cap + 0.5 ml of solvent in pre-filled syringe (type I glass), with a plunger-stopper (chlorobromobutyl), without attached needle and tip cap (chlorobromobutyl) with 1 or 2 separate needles attached in the blister– pack size of 1 and 10.
Prašek v viali (steklo tipa I), z zamaškom (klorobutil) in aluminijasto zaporko + 0, 5 ml topila v napolnjeni injekcijski brizgi (steklo tipa I), z zamaškom na batu (klorobromobutil), brez pritrjene igle in pokrova za konico (klorobromobutil), z 1 ali 2 ločenima iglama, priloženima v pretisnem omotu - velikost zavoja po 1 in 10.
Not all pack sizes or presentations may be marketed.
Na trgu ni vseh navedenih pakiranj.
6.6 Special precautions for disposal
6. 6 Posebni previdnostni ukrepi pri odstranjevanju
For syringe without attached needle only:
Samo za brizgalko brez pritrjene igle:
After removing the syringe tip cap, the needle should be firmly placed on the tip of the syringe and secured by rotating a quarter of a turn (90°).
Po odstranitvi pokrova za konico brizgalke je treba iglo trdno namestiti na konico brizgalke in jo zavarovati z vrtenjem za eno četrtino obrata (90°).
The powder is reconstituted by adding the solvent provided in the pre-filled syringe to the vial.
Prašek se rekonstituira z dodajanjem topila iz napolnjene injekcijske brizge v vialo.
The vial is shaken and, after complete dissolution, the suspension obtained is withdrawn into this same syringe for injection.
Vialo se pretrese in po popolni raztopitvi se nastalo suspenzijo potegne nazaj v isto brizgalko za injiciranje.
Before administration, the reconstituted vaccine should be shaken vigorously.
Pred injiciranjem je treba rekonstituirano cepivo močno pretresti.
After reconstitution with the sodium chloride solution provided STAMARIL is a beige to pink beige suspension for injection.
Po rekonstituciji s priloženo raztopino natrijevega klorida je STAMARIL suspenzija za injiciranje beige do rožnato- beige barve.
Contact with disinfectants is to be avoided since they may inactivate the virus.
Stiku z razkužili se je treba izogibati, ker lahko inaktivirajo virus.
Any unused product or waste material should be disposed of, preferably by heat inactivation or incineration, in accordance with local requirements.
Neuporabljeno zdravilo ali odpadni material zavrzite v skladu z lokalnimi predpisi, po možnosti s toplotno inaktivacijo ali sežigom.
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
DATUM PRVE ODOBRITVE/ OBNOVITVE DOVOLJENJA ZA PROMET
20 SUMMARY OF PRODUCT CHARACTERISTICS
21 POVZETEK GLAVNIH ZNAČILNOSTI ZDRAVILA
MULTIDOSE PRESENTATION
VEČ ODMERNO PAKIRANJE
This presentation is not applicable in all countries.
To pakiranje ne bo prisotno v vseh državah.
The SPC will be completed nationally
SPC bo določen nacionalno.
22 6 months up to 9 months except in specific circumstances and in accordance with available official recommendations (see section 4.4), in which case the dose is the same as in older children and adults.
Pri otrocih od 6 do 9 mesecev starosti cepljenje proti rumeni mrzlici običajno ni priporočljivo, razen v specifičnih okoliščinah in v skladu z razpoložljivimi uradnimi priporočili (glejte poglavje 4. 4), v teh primerih je odmerek enak kot pri starejših otrocih in odraslih.
The vaccine should be given at least 10 days before entering an endemic area since protective immunity may not be achieved until at least this time has elapsed.
23 Cepljenje je treba opraviti vsaj 10 dni pred vstopom na endemično področje, saj zaščitna imunost ni zanesljivo dosežena pred pretekom tega časovnega obdobja.
23 considering administration of yellow fever vaccine, care should be taken to identify those who might be at increased risk of adverse reactions following vaccination (see section 4.3 and below).
Pred odločitvijo za cepljenje s cepivom proti rumeni mrzlici je treba poskrbeti za prepoznavo oseb z visokim tveganjem za neželene reakcije po cepljenju (glejte poglavje 4. 3 in spodaj).
Yellow fever vaccine associated neurotropic disease Very rarely, yellow fever vaccine-associated neurotropic disease (YEL-AND) has been reported following vaccination, with sequelae or with fatal outcome in some cases (see section 4.8).
24 Nevrotropna bolezen, povezana s cepivom proti rumeni mrzlici Obstajajo zelo redka poročila o nevrotropni bolezni, povezani s cepivom proti rumeni mrzlici (YEL - AND), ki se pojavi po cepljenju, v nekaterih primerih s posledicami ali s smrtnim izidom (glejte poglavje 4. 8).
24 Because intramuscular injection can cause injection site haematoma, STAMARIL should not be given by the intramuscular route to persons with any bleeding disorder, such as haemophilia or thrombocytopenia, or to persons on anticoagulant therapy.
25 Intramuskularna injekcija lahko povzroči hematom na vbodnem mestu, zato se cepiva STAMARIL ne sme injicirati intramuskularno osebam z motnjami strjevanja krvi, naprimer s hemofilijo ali trombocitopenijo, ali osebam na antikoagulantni terapiji.
25 Gastro-intestinal system disorders Common:
26 Presnovne in prehranske motnje Pogosti:
26 5.1 Pharmacodynamic properties
5. 1 Farmakodinamične lastnosti
Pharmacotherapeutic group:
27 Farmakoterapevtska skupina:
This vaccine must not be mixed with other medicinal products.
Inkompatibilnosti
After reconstitution, the product must be kept in a refrigerator (2°C - 8°C) and must be used within 6 hours.
Po rekonstituciji je treba zdravilo hraniti v hladilniku (2°C - 8°C) in ga uporabiti v 6 urah.
27 For storage conditions of the reconstituted medicinal product, see section 6.3
28 Za pogoje shranjevanja rekonstituiranega zdravila glejte poglavje 6. 3.
Powder (10 doses) in vial (type I glass), with a stopper (chlorobutyl) + 5 ml of solvent in a vial (type I glass), with a stopper (chlorobutyl)– Pack size of 1, 10 or 20.
Prašek (10 odmerkov) v viali (steklo tipa I), z zamaškom (klorobutil) + 5 ml topila v viali (steklo tipa I), z zamaškom (klorobutil) - velikost zavoja po 1, 10 ali 20.
6.6 Special precautions for disposal
Posebni previdnostni ukrepi pri odstranjevanju
The powder is reconstituted in its container with a small quantity of sodium chloride 9 mg/ml (0.9%) solution for injection.
Prašek se rekonstituira v sami viali z manjšo količino raztopine za injekcije, ki vsebuje 9 mg/ ml natrijevega klorida (0, 9%).
The vial is shaken and after dissolution, the suspension obtained is withdrawn and added to the remaining solution.
Vialo se stresa in po raztopitvi se suspenzijo izprazni v drugo vialo z ostankom topila.
Before administration, the reconstituted vaccine is vigorously shaken.
Pred injiciranjem je potrebno vialo dobro pretresti.
For each vaccination 0.5 ml is withdrawn.
Za vsako injiciranje odvzamemo 0, 5 ml suspenzije.
The reconstitution and withdrawal of vaccine should be performed under aseptic conditions.
Rekonstitucijo in vsak odvzem cepiva je treba izvajati v aseptičnih pogojih.
After reconstitution STAMARIL is a beige to pink beige suspension for injection.
Po rekonstituciji s priloženo raztopino natrijevega klorida je STAMARIL suspenzija za injiciranje beige do rožnato- beige barve.
Contact with disinfectant is to be avoided since they may inactivate the virus.
Stiku z razkužili se je treba izogibati, ker lahko inaktivirajo virus.
29 LABELLING
29 OZNAČEVANJE IN NAVODILO ZA UPORABO
STAMARIL - Carton for Vial 0.5 ml and syringe – Box of 1 – 10 - 20
STAMARIL – škatla za vialo 0, 5 ml in napolnjeno injekcijsko brizgo - pakiranja po 1 – 10 - 20
STAMARIL (or invented name) Powder and solvent for suspension for injection Yellow fever vaccine (Live).
Cepivo proti rumeni mrzlici, živo
Yellow fever virus1 17 D-204 strain (live, attenuated) ………………….not less than 1000 LD50 units2 1 produced in specified pathogen-free chick embryos 2 The statistically determined lethal dose in 50% of animals tested
Virus rumene mrzlice1 sev 17 D- 204 (živ, oslabljen)................................ vsaj 1000 LD50 enot2 1 vzgojen na specificiranih piščančjih zarodkih brez patogenov 2 statistično ugotovljen smrtni odmerek pri 50% testiranih živali
Powder: lactose, sorbitol, L-histidine hydrochloride, L-alanine, sodium chloride, potassium chloride, disodium phosphate, monopotassium phosphate, calcium chloride, magnesium sulphate Solvent: sodium chloride (0.4%), water for injections.
Prašek: laktoza monohidrat, sorbitol E4 20, L- histidinijev klorid monohidrat, L- alanin, natrijev klorid, kalijev klorid, natrijev hidrogenfosfat dihidrat, kalijev dihidrogenfosfat, kalcijev klorid dihidrat, magnezijev sulfat heptahidrat Vehikel: natrijev klorid, voda za injekcije
Powder and solvent for suspension for injection This pack contains 1 single dose vial + 1 pre-filled syringe This pack contains 10 single dose vials + 10 pre-filled syringes This pack contains 20 single dose vials + 20 pre-filled syringes
Pakiranje vsebuje 1 vialo z enim odmerkom + 1 napolnjeno injekcijsko brizgo Pakiranje vsebuje 10 vial z enim odmerkom + 10 napolnjenih injekcijskih brizg Pakiranje vsebuje 20 vial z enim odmerkom + 20 napolnjenih injekcijskih brizg
Subcutaneous or Intramuscular use.
Subkutana ali intramuskularna uporaba.
31 8.
32 8.
< [To be completed nationally] >
< [To be completed nationally >]
MARKETING AUTHORISATION NUMBER(S)
ŠTEVILKA( E) V REGISTRU ZDRAVIL SKUPNOSTI
Lot
Št. serije:
< [To be completed nationally] > Medicinal product subject to medical prescription.
< [To be completed nationally >] Izdaja zdravila je le na recept.
INFORMATION IN BRAILLE
NAVODILA V BRAILLE
32 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
33 PODATKI NA ZUNANJI OVOJNINI
STAMARIL - Carton for Vial 0.5 ml and syringe without needle with 1 separated needle – box of 1 – 10
STAMARIL – škatla za vialo 0, 5 ml in napolnjeno injekcijsko brizgo brez injekcijske igle z 1 priloženo injekcijsko iglo - pakiranja po 1 – 10
This pack contains 1 single dose vial + 1 pre-filled syringe with 1 separated needle This pack contains 10 single dose vials + 10 pre-filled syringes with 10 separated needle
Pakiranje vsebuje 1 vialo z enim odmerkom + 1 napolnjeno injekcijsko brizgo z 1 priloženo injekcijsko iglo Pakiranje vsebuje 10 vial z enim odmerkom + 10 napolnjenih injekcijskih brizg z 10 priloženimi injekcijskimi iglami
Subcutaneous or intramuscular use.
Subkutana ali intramuskularna uporaba.
34 PARTICULARS TO APPEAR ON < THE OUTER PACKAGING
35 PODATKI NA ZUNANJI OVOJNINI
STAMARIL - Carton for Vial 0.5 ml and syringe without needle with 2 separated needles – box of 1 – 10
STAMARIL – škatla za vialo 0, 5 ml in napolnjeno injekcijsko brizgo brez injekcijske igle z 2 priloženima injekcijskima iglama - pakiranja po 1 – 10
Powder and solvent for suspension for injection This pack contains 1 single dose vial + 1 pre-filled syringe with 2 separated needles This pack contains 10 single dose vials + 10 pre-filled syringes with 20 separated needles
Pakiranje vsebuje 1 vialo z enim odmerkom + 1 napolnjeno injekcijsko brizgo z 2 priloženima injekcijskima iglama Pakiranje vsebuje 10 vial z enim odmerkom + 10 napolnjenih injekcijskih brizg z 10 priloženimi injekcijskimi iglami
Subcutaneous of intramuscular use.
Subkutana ali intramuskularna uporaba.
36 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
37 PODATKI NA ZUNANJI OVOJNINI
STAMARIL - Carton for Vial 0.5 ml and syringe without needle – box of 1, 10
STAMARIL – škatla za vialo 0, 5 ml in napolnjeno injekcijsko brizgo brez injekcijske igle - pakiranja po 1, 10
This pack contains 1 single dose vial + 1 pre-filled syringe without needle This pack contains 10 single dose vials + 10 pre-filled syringes without needle
Pakiranje vsebuje 1 vialo z enim odmerkom + 1 napolnjeno injekcijsko brizgo brez injekcijske igle Pakiranje vsebuje 10 vial z enim odmerkom + 10 napolnjenih injekcijskih brizg brez injekcijskih igel
37 EXP
Uporabno do:
< [To be completed nationally] > Medicinal product subject to medical prescription.
Izdaja zdravila je le na recept.
38 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
39 PODATKI, KI OVOJNINAH
STAMARIL – Vial single dose
STAMARIL – viala z enim odmerkom
SC or IM use
SC ali IM uporaba
39 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
40 PODATKI, KI OVOJNINAH
Pre-filled syringe of solvent 4 mg/ml (0.4%)
STAMARIL – napolnjena injekcijska brizga z topilom 4 mg / ml (0, 4%)
Solvent for STAMARIL Sodium chloride 0.4% solution for injection
Topilo za STAMARIL Natrijev klorid 0, 4% raztopina za suspenzijo za injiciranje.
40 LABELLING
DRUGI PODATKI
41 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
41 OZNAČEVANJE
STAMARIL - Carton for Vial 5 ml and vial – Box of 10 – will be completed nationally
STAMARIL – škatla za vialo 5 ml in vialo z 5ml topila - pakiranje po 10 – bo določeno nacionalno
STAMARIL (or local trade name) Powder and solvent for suspension for injection Yellow fever vaccine (Live).
Cepivo proti rumeni mrzlici, živo
Solvent: sodium chloride (0.9%), water for injections.
Prašek: laktoza monohidrat, sorbitol E4 20, L- histidinijev klorid monohidrat, L- alanin, natrijev klorid, kalijev klorid, natrijev hidrogenfosfat dihidrat, kalijev dihidrogenfosfat, kalcijev klorid dihidrat, magnezijev sulfat heptahidrat Vehikel: natrijev kloridb (0, 9%), voda za injekcije
This pack contains 10 multi dose vials + 10 vials.
Pakiranje vsebuje 10 vial z 10 odmerki + 10 vial z 5 ml topila
43 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
44 PODATKI, KI OVOJNINAH
STAMARIL – Vial multi dose will be completed nationally
STAMARIL – viala z desetimi odmerki bo določena ncionalno
STAMARIL (or local trade name) powder and solvent for suspension for injection in vial.
STAMARIL Prašek in vehikel za suspenzijo za injiciranje.
10 doses.
10 odmerkov
44 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
45 PODATKI, KI OVOJNINAH
Vial of solvent 9 mg/ml (0.9%) will be completed nationally
Viala z topilom 9 mg / ml (0, 9%) bo določena nacionalno
Solvent for STAMARIL Sodium chloride 0.9% solution for injection
Topilo za STAMARIL Natrijev klorid 0, 9% raztopina za suspenzijo za injiciranje.
45 PACKAGE LEAFLET
DRUGI PODATKI
STAMARIL, Powder and solvent for suspension for injection Yellow fever vaccine (Live).
STAMARIL, prašek in vehikel za suspenzijo za injiciranje Cepivo proti rumeni mrzlici, živo
Read all of this leaflet carefully before you/your child are vaccinated.
Pred uporabo natančno preberite navodilo!
- This vaccine has been prescribed for you.
- To cepivo je bilo predpisano vam osebno in ga ne smete dajati drugim.
- If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet,
- Če katerikoli neželeni učinek postane resen ali če opazite kakršenkoli neželeni učinek, ki ni omenjen
What STAMARIL is and what it is used for 2.
Kaj je zdravilo STAMARIL in za kaj ga uporabljamo 2.
Before you use STAMARIL 3.
Kaj morate vedeti, preden boste uporabili STAMARIL 3.
How to use STAMARIL 4.
Kako uporabljati zdravilo STAMARIL 4.
How to store STAMARIL 6.
Shranjevanje zdravila STAMARIL 6.
WHAT STAMARIL IS AND WHAT IT IS USED FOR
KAJ JE ZDRAVILO STAMARIL IN ZA KAJ GA UPORABLJAMO
STAMARIL is an injectable vaccine against a serious infectious disease called yellow fever.
STAMARIL je injekcijsko cepivo proti resni infekcijski bolezni, ki se imenuje rumena mrzlica.
Yellow fever occurs in certain areas of the world and is spread to man through the bites of infected mosquitoes.
Rumena mrzlica se pojavlja v določenih področjih sveta in se širi na človeka z ugrizi okuženih komarjev.
STAMARIL is intended to be given to:
STAMARIL je namenjen za cepljenje:
Persons who may handle infectious materials such as laboratory workers.
Oseb, ki potujejo, se prehodno zadržujejo ali živijo na področju, kjer se pojavlja rumena mrzlica, Oseb, ki potujejo v katerokoli državo, ki za vstop zahteva Mednarodno knjižico o cepljenju (kar je lahko odvisno ali neodvisno od predhodno obiskanih držav v okviru istega potovanja) Oseb, ki rokujejo s kužnimi snovmi, na primer laboratorijskih delavcev.
To obtain a valid vaccination certificate against yellow fever it is necessary to be vaccinated in an approved vaccination centre so that an International Certificate of Vaccination can be issued.
Za pridobitev veljavnega potrdila o cepljenju proti rumeni mrzlici je treba cepljenje opraviti v pooblaščenem centru za cepljenje, kjer se lahko izda potrdilo v Mednarodni knjižici o cepljenju.
This certificate is valid from 10 days until 10 years after the first dose of vaccine.
To potrdilo velja od 10 dni do 10 let po prvem odmerku cepiva.
Certificates issued after booster doses (see section 3 below) are valid immediately after the injection.
Potrdila, ki se izdajo po poživitvenih odmerkih (glejte poglavje 3 spodaj) veljajo takoj po injekciji.
BEFORE YOU USE STAMARIL
PREDEN UPORABITE STAMARIL
To make sure that STAMARIL is suitable for you or your child it is important to tell the doctor or nurse if any of the points below apply to the person receiving the vaccine.
Zaradi zagotovila, da je STAMARIL ustrezen za vas ali vašega otroka, je pomembno, da zdravniku ali medicinski sestri poveste, če se katera od spodaj navedenih točk nanaša na prejemnika cepiva.
If there is anything you do not understand, ask the doctor or nurse to explain.
Če česarkoli ne razumete, vprašajte zdravnika ali medicinsko sestro za razlago.
Do not use STAMARIL
Ne uporabljajte zdravila STAMARIL
The following questions apply to the person who is to receive the vaccine regardless of age:
Naslednja vprašanja se nanašajo na osebo, ki naj bi prejela cepivo, ne glede na starost:
- If you are allergic (hypersensitive) to eggs, chicken proteins or any of the components of
- Če ste alergični (preobčutljivi) na jajca, piščančje proteine ali na katerokoli sestavino cepiva
STAMARIL, or if you have experienced a serious reaction after a previous dose of any yellow fever vaccine.
STAMARIL, ali če ste po predhodnem odmerku kateregakoli cepiva proti rumeni mrzlici doživeli hudo reakcijo.
- If you have been told that you have poor immunity to infections for any reason, such as due to
- Če so vam povedali, da imate slabo imunost na okužbe zaradi kateregakoli vzroka, na primer zaradi
illness or due to medical treatments that may weaken your immune system (for example corticoids or chemotherapy)
bolezni ali zaradi zdravljenja, ki lahko oslabi vaš imunski sistem (npr. kortikosteroidi ali kemoterapija).
- If you have a h istory of problems with your thymus gland or have had your thymus gland
- Če imate v anamnezi težave s timusom ali če so vam zaradi kateregakoli vzroka odstranili timus.
removed for any reason
48
- If you are infected by the HIV virus and have active symptoms due to the infection
- Če ste okuženi z virusom HIV in imate aktivne simptome okužbe.
- If you are infected by the HIV virus and your laboratory results show that your immune system
- Če ste okuženi z virusom HIV in vaši laboratorijski rezultati kažejo, da vaš imunski sistem ne deluje
is not working very well..
dobro.
Your doctor will advise you if you can still have STAMARIL based on the results of your blood tests.
Vaš zdravnik vam bo na podlagi krvnih testov svetoval, ali lahko kljub temu prejmete STAMARIL.
- If you have an infection with a fever.
- Če prebolevate okužbo z vročino.
Vaccination should be postponed until after you have
Cepljenje je treba odložiti, dokler ne okrevate.
- Please note that STAMARIL must not be given to children aged less than 6 months.
- Prosimo, upoštevajte, da se cepiva STAMARIL ne sme dati otrokom, ki so mlajši od 6 mesecev.
Take special care with STAMARIL
Bodite posebno previdni pri uporabi cepiva STAMARIL
- If you are more than 60 years old.
- Če ste starejši od 60 let.
Persons aged over 60 years appear to run an increased risk of
Zdi se, da imajo osebe po 60. letu starosti povišano tveganje za določene
certain types of severe but rare reactions to yellow fever vaccines that include effects on the brain and nerves or an illness that resembles yellow fever itself, with widespread symptoms affecting most body systems.
vrste hudih, vendar redkih reakcij na cepiva proti rumeni mrzlici, kar vključuje učinke na možgane in živce ali rumeni mrzlici podobno bolezen s splošnimi simptomi, ki prizadenejo večino telesnih sistemov.
Therefore persons aged over 60 years are usually only given yellow fever vaccine if they are going to run a considerable and unavoidable risk of infection with the virus.
Zato se osebe po 60. letu starosti običajno cepi proti rumeni mrzlici le v primeru, če obstaja veliko in neizogibno tveganje za okužbo z virusom..
- If your child is aged 6 to 9 months.
- Če je vaš otrok star od 6 do 9 mesecev.
STAMARIL may be given to children aged between 6 and 9
STAMARIL se lahko uporabi pri otrocih od 6 do 9 mesecev
months only in special situations and on the basis of current official advice.
starosti le v posebnih okoliščinah na podlagi veljavnih uradnih priporočil.
- If you are infected by the HIV virus but do not have active symptoms due to the infection your
- Če ste okuženi z virusom HIV in nimate aktivnih simptomov okužbe, vam bo vaš zdravnik na
doctor will advise you if you can have STAMARIL based on the results of laboratory tests.
podlagi rezultatov laboratorijskih testov svetoval, ali lahko prejmete STAMARIL.
- If your child is infected with the HIV (AIDS) virus the doctor may need to do special tests and
- Če je vaš otrok okužen z virusom HIV (AIDS), bo vaš zdravnik moral opraviti posebne teste in
to obtain special advice before advising you if the child can receive STAMARIL.
pridobiti posebno mnenje, preden vam bo svetoval, ali otrok lahko prejme STAMARIL.
- If you have any bleeding disorder (such as haemophilia or low level of platelets) or are taking
- Če imate kakršnokoli motnjo strjevanja krvi (na primer hemofilijo ali nizko koncentracijo
any medicines that stop the blood clotting normally.
trombocitov) ali če jemljete zdravila proti strjevanju krvi.
You can still be given STAMARIL provided that it is injected under the skin and not into muscle (see section 3).
Kljub temu lahko prejmete STAMARIL, pod pogojem, da se injicira pod kožo in ne v mišico (glejte poglavje 3).
If you have recently been receiving any treatment which may have weakened your immune system, vaccination against yellow fever should be postponed until your laboratory results show that your immune system has recovered.
Če ste nedavno prejemali zdravila, ki bi lahko oslabila vaš imunski sistem, je treba cepljenje proti rumeni mrzlici odložiti, dokler vaši laboratorijski rezultati ne pokažejo, da si je vaš imunski sistem opomogel.
Your doctor will advise you when it is safe for you to be vaccinated.
Vaš zdravnik vam bo svetoval, kdaj bo cepljenje za vas varno.
STAMARIL can be given at the same time as measles vaccine or vaccines against typhoid (those containing the Vi capsular polysaccharide) and/or hepatitis A..
STAMARIL se lahko uporabi hkrati s cepivom proti ošpicam ali s cepivom proti tifusu (ki vsebuje Vi kapsularni polisaharid) in/ ali hepatitisu A.
Pregnancy and breastfeeding Females who are pregnant, think they might be pregnant or who are breastfeeding a child are not usually given STAMARIL unless this cannot be avoided.
Žensk, ki so noseče, bi lahko bile noseče ali dojijo otroka, se običajno ne cepi s cepivom STAMARIL, razen če je to neizogibno.
Your doctor or nurse can advise you on whether it is essential that you are vaccinated while pregnant or breastfeeding.
Vaš zdravnik ali medicinska sestra vam bosta svetovala, ali je nujno, da se cepite v času nosečnosti ali dojenja.
Important information about some of the ingredients of STAMARIL STAMARIL contains a small amount of sorbitol.
Pomembne informacije o nekaterih sestavinah cepiva STAMARIL STAMARIL vsebuje majhno količino sorbitola.
The vaccine should not be given to people who have fructose intolerance.
Če vam je zdravnik povedal, da imate intoleranco za nekatere sladkorje, se pred uporabo tega zdravila posvetujte s svojim zdravnikom.
HOW TO USE STAMARIL
KAKO UPORABLJATI ZDRAVILO STAMARIL
Initial (first) dose of yellow fever vaccine STAMARIL should be given at least 10 days before putting yourself at any risk of infection because the vaccine may not provide good protection before the 10th day.
STAMARIL je treba uporabiti vsaj 10 dni pred izpostavljenostjo tveganju za okužbo, ker cepivo ne zagotavlja zadostne zaščite pred 10. dnevom.